Protalix BioTherapeutics
PLX
#8878
Rank
S$0.22 B
Marketcap
S$2.73
Share price
1.90%
Change (1 day)
35.98%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): S$9.9 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$61.84 Million. In 2024 the company made an earning of S$6.66 Million a decrease over its 2023 earnings that were of S$15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$9.9 M48.69%
2024 S$6.66 M-55.62%
2023 S$15 M-199.05%
2022 -S$15.16 Million-40.38%
2021 -S$25.42 Million-732.31%
2020 S$4.01 M-130.53%
2019 -S$13.17 Million189.85%
2018 -S$4.55 Million-95.29%
2017 -S$96.48 Million308.12%
2016 -S$23.64 Million-32.37%
2015 -S$34.96 Million10.11%
2014 -S$31.75 Million-7.59%
2013 -S$34.35 Million
2011 -S$39.78 Million-19.39%
2010 -S$49.35 Million20.87%
2009 -S$40.83 Million32.26%
2008 -S$30.87 Million-5.46%
2007 -S$32.65 Million
2004 -S$0.22 Million12.35%
2003 -S$0.19 Million-11.1%
2002 -S$0.22 Million-57.03%
2001 -S$0.5 Million1.03%
2000 -S$0.49 Million-53.22%
1999 -S$1.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.52 B 141,889.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.02 B 10,609.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.89 B 30,346.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel